COMMUNIQUÉS West-GlobeNewswire

Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018

19/12/2017 - 12:00

BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Amphastar Announces Approval for Sodium Nitroprusside Injection, USP

19/12/2017 - 12:00

RANCHO CUCAMONGA, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that today the U.S. Food and Drug Administration (“FDA”) granted approval of its abbreviated new drug [...]

Transactions in relation to share buyback program

19/12/2017 - 11:23

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

HealthLynked Corp. Announces 12,926 Patient Member Profiles in Florida

19/12/2017 - 11:00

NAPLES, Fla., Dec. 19, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced it now has added 12,926 patient profiles in its Florida market. Dr. Michael Dent, Chairman and Chief Executive Officer [...]

Saniona AB: Saniona Spin-Out, Scandion Oncology Raises DKK 2 Million and Prepares for a Potential Public Listing

19/12/2017 - 09:46

PRESS RELEASE December 19, 2017 Saniona, a leading biotech company in the field of ion channels, today announced that its spin-out company, Scandion Oncology, has raised DKK 2 million in a private placement. Scandion [...]

OSE Immunotherapeutics Presents New Data Analysis Supporting Continued Development of OSE-127 in Inflammatory Bowel Diseases

19/12/2017 - 08:00

OSE-127 shown to have significant potential in patients with inflammatory bowel diseases (IBD) in therapeutic escape and with a strong medical need. Interleukin-7 receptor (IL-7R), target of OSE-127, overexpressed in [...]

BIOPHYTIS to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018

19/12/2017 - 07:45

PARIS, Dec. 19, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS) , a biotechnology company specializing in the development of drug candidates to treat age-related diseases, today announced that its [...]

NICOX :Réalisations de 2017, lancement commercial de VYZULTA et aperçu des activités pour 2018

19/12/2017 - 07:31

Communiqué de presse Nicox : Réalisations de 2017, lancement commercial de VYZULTA TM et aperçu des activités pour 2018 Nicox rejoint les quelques sociétés européennes de R&D ayant des médicaments approuvés par la [...]

Nicox Recaps 2017 Achievements, Provides Update on Commercial Availability of VYZULTA and Outlines 2018 Activities

19/12/2017 - 07:31

Press Release Nicox Recaps 2017 Achievements, Provides Update on Commercial Availability of VYZULTA TM and Outlines 2018 Activities Nicox joins the select group of European R&D companies with U.S. FDA approved [...]

Cannabis Wheaton Income Corp. Announces Exclusive Data Licensing Agreement With Prominent Cannabis Testing, Analysis and Rating Company

19/12/2017 - 06:01

VANCOUVER, British Columbia, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (“ Wheaton Income ” or the “ Company ”) is pleased to announce that it has entered into an [...]

Madrigal Pharmaceuticals Prices Public Offering of Common Stock

19/12/2017 - 05:26

CONSHOHOCKEN, Pa., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL ), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]

Akers Biosciences Prices $6,000,000 Public Offering

19/12/2017 - 04:01

THOROFARE, N.J, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today announces the pricing of [...]

DiaMedica Therapeutics Completes Non-Brokered Private Placement

19/12/2017 - 01:41

MINNEAPOLIS, Dec. 18, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF) announced today the closing of its previously announced non-brokered private placement raising [...]

Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu™ Vaccine

18/12/2017 - 22:32

RSV F Vaccine informational analysis completed in fourth quarter of 2017 RSV F Vaccine interim analysis expected mid-2018 with approximately 4,600 enrollees Filing of RSV F Vaccine BLA anticipated by late 2019 NanoFlu [...]

Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco

18/12/2017 - 22:30

BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Alpha Pro Tech, Ltd. Announces Passing of Al Millar, Founder, President and Chairman

18/12/2017 - 22:15

NOGALES, Ariz., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American:APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

Oncolix, Inc., Announces Approval for Listing on OTC-QB

18/12/2017 - 22:10

HOUSTON, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTC PINK:ONCX) announced today that the Company has been given approval by the OTC Markets to be listed and traded on the OTC-QB effective at the opening of [...]

Flexion Therapeutics Enrolls First Patient in Study Evaluating the Pharmacokinetics and Safety of ZILRETTA™ (triamcinolone acetonide extended-release injectable suspension) in Osteoarthritis of the Shoulder and Hip

18/12/2017 - 22:05

BURLINGTON, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) announced today that it has enrolled the first patient in a clinical trial to evaluate the pharmacokinetics and safety of [...]

argenx announces closing of U.S. public offering for gross proceeds of approximately $266 million

18/12/2017 - 22:01

Regulated information December 18, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based [...]